Literature DB >> 7591128

Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains.

J P Nataro1, J Seriwatana, A Fasano, D R Maneval, L D Guers, F Noriega, F Dubovsky, M M Levine, J G Morris.   

Abstract

We have employed a molecular genetic approach to characterize the nature of enteroinvasive Escherichia coli (EIEC) enterotoxic activity, as previously observed in Ussing chambers (A. Fasano, B.A. Kay, R.G. Russell, D.R. Maneval, Jr., and M.M. Levine, Infect. Immun. 58:3717-3723, 1990). The screening of TnphoA mutants of EIEC yielded a single insertion mutant which had significantly reduced levels of enterotoxic activity in the Ussing chamber assay. DNA flanking the insertion was used as a probe to screen for EIEC cosmid clones which conferred secretogenic activity. Such screening resulted in the identification of two overlapping cosmid clones which elicited significant changes in mucosal short-circuit current (Isc). Subcloning and nucleotide sequence analysis of a DNA fragment from one of the cosmid clones led to the identification of a single open reading frame which conferred this enterotoxic activity. By DNA hybridization, this gene (designated sen for shigella enterotoxin) was found in 75% of EIEC strains and 83% of Shigella strains and was localized to the inv plasmid of Shigella flexneri 2457T. By PCR, a sen gene with 99.7% nucleotide identity was cloned and sequenced from 2457T. A deletion in the EIEC sen gene was constructed by allelic exchange, resulting in significantly lower rises in Isc than were elicited by the wild-type parent; however, significant enterotoxic activity remained in the sen deletion mutant. To purify the Sen protein, the gene was cloned into the multiple cloning site of the expression vector pKK223-3. Purification of the sen gene product yielded a protein with a molecular mass of 63 kDa which elicited rises in Isc in the Ussing chamber. We believe that the sen gene product may constitute all or part of a novel enterotoxin in EIEC and Shigella spp.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591128      PMCID: PMC173677          DOI: 10.1128/iai.63.12.4721-4728.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens.

Authors:  G P Andrews; A E Hromockyj; C Coker; A T Maurelli
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

3.  Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Authors:  K L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; M M Levine
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

5.  Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies.

Authors:  W R Rout; S B Formal; R A Giannella; G J Dammin
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

Review 6.  Shigella subversion of the cellular cytoskeleton: a strategy for epithelial colonization.

Authors:  M B Goldberg; P J Sansonetti
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a.

Authors:  M D Kinsey; S B Formal; G J Dammin; R A Giannella
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri lpa invasins.

Authors:  A Allaoui; P J Sansonetti; C Parsot
Journal:  Mol Microbiol       Date:  1993-01       Impact factor: 3.501

9.  Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.

Authors:  A Fasano; F R Noriega; D R Maneval; S Chanasongcram; R Russell; S Guandalini; M M Levine
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more
  78 in total

1.  Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea.

Authors:  M Vargas; J Gascon; M T Jimenez De Anta; J Vila
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Authors:  K Al-Hasani; I R Henderson; H Sakellaris; K Rajakumar; T Grant; J P Nataro; R Robins-Browne; B Adler
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

4.  Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48.

Authors:  Songhai Shen; Mariola Mascarenhas; Kris Rahn; James B Kaper; Mohamed A Karmali; Mohamed A Karmal
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 5.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

6.  Overproduction, purification and preliminary X-ray diffraction analysis of YncE, an iron-regulated Sec-dependent periplasmic protein from Escherichia coli.

Authors:  Aisha Baba-Dikwa; Darren Thompson; Nick J Spencer; Simon C Andrews; Kimberly A Watson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-09-30

7.  Investigating the Relatedness of Enteroinvasive Escherichia coli to Other E. coli and Shigella Isolates by Using Comparative Genomics.

Authors:  Tracy H Hazen; Susan R Leonard; Keith A Lampel; David W Lacher; Anthony T Maurelli; David A Rasko
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

9.  Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp.

Authors:  Ruiting Lan; M Chehani Alles; Kathy Donohoe; Marina B Martinez; Peter R Reeves
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.